IRMD logo

IRADIMED CORPORATION Stock Price

NasdaqGM:IRMD Community·US$1.2b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

IRMD Share Price Performance

US$93.57
33.21 (55.02%)
US$118.00
Fair Value
US$93.57
33.21 (55.02%)
20.7% undervalued intrinsic discount
US$118.00
Fair Value
Price US$93.57
AnalystConsensusTarget US$118.00

IRMD Community Narratives

·
Fair Value US$118 20.7% undervalued intrinsic discount

IRMD: Index Addition and Strong Margins Will Support Measured Upside

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
US$118
20.7% undervalued intrinsic discount
Revenue
9.66% p.a.
Profit Margin
28.09%
Future PE
55.08x
Price in 2029
US$135.69

Trending Discussion

Updated Narratives

IRMD logo

IRMD: 2026 Guidance And Bullish Coverage Will Support Further Re Rating

Fair Value: US$118 20.7% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
2 Rewards

IRADIMED CORPORATION Key Details

US$86.3m

Revenue

US$20.0m

Cost of Revenue

US$66.3m

Gross Profit

US$42.7m

Other Expenses

US$23.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
1.85
76.84%
27.36%
0%
View Full Analysis

About IRMD

Founded
1992
Employees
166
CEO
Roger Susi
WebsiteView website
www.iradimed.com

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Recent IRMD News & Updates

Narrative Update Jun 04

IRMD: 2026 Guidance And Bullish Coverage Will Support Further Re Rating

Analysts have nudged their price target on IRADIMED slightly lower, from about $118.67 to $118.00. They are refining assumptions around discount rates, revenue growth, margins and future P/E expectations following recent bullish Street coverage.

Recent updates

No updates